Medicalgorithmics S.A. (B8E)

Overview

Medicalgorithmics S.A. is a pioneering company operating in the field of medical technology, with a focus on advancing cardiac diagnostic solutions. Established in 2005 and based in Warsaw, Poland, the company has expanded its operations to the United States and other countries, showcasing a global impact. Medicalgorithmics S.A. has dedicated itself to innovation in heart health monitoring and diagnosis, spotlighting the integration of advanced technology and artificial intelligence to refine and enhance cardiac care. Their contributions to medical technology, especially in cardiac diagnostics, signify a commitment to improving patient outcomes and advancing the efficiency and accuracy of heart disease detection.

Products and Services

Medicalgorithmics S.A. has developed a robust portfolio of products and services designed to address various aspects of cardiac care, utilizing cutting-edge technology and AI to offer comprehensive solutions:

• PocketECG: This is a state-of-the-art diagnostic tool for arrhythmia, delivering detailed ECG signal analysis, full data capture, and comprehensive reporting. PocketECG sets a new standard in mobile cardiac monitoring, offering real-time, continuous heart rhythm and ECG monitoring that supports accurate diagnosis.
• DeepRhythmAI: An AI-powered device specialized in ECG analysis, DeepRhythmAI leverages artificial intelligence to enhance the precision and efficiency of ECG interpretation, facilitating early detection and intervention in cardiac care.
• Virtual Cardiac Stress Test: Utilizing AI technology, this medical system is designed to non-invasively assess coronary artery atherosclerotic stenosis, offering a safer and more accessible alternative to traditional stress testing methodologies.
• ECG TechBot: Currently under development, ECG TechBot is a software solution employing a sophisticated set of algorithms for automatic analysis and interpretation of ECG signals, aiming to streamline and improve the accuracy of diagnostic processes.
• PatchECG: This innovative device enables one-channel offline monitoring, designed for patients requiring extended cardiac monitoring. PatchECG represents a significant advancement in wearable heart health technology, offering convenience and efficiency in patient care.
• NextGen: A software upgrade for PocketECG, NextGen aims to further enhance the capabilities of this diagnostic solution, incorporating the latest advancements in technology to provide even more accurate and reliable cardiac monitoring.

In addition to these pioneering products, Medicalgorithmics S.A. offers a range of services encompassing information technology, ECG monitoring, scientific research and development, all while manufacturing electrical equipment for medical use. This comprehensive suite of solutions underscores the company's commitment to pushing the boundaries of cardiac care and technology.